Ipamorelin Peptide

What ipamorelin is

Ipamorelin is a growth-hormone secretagogue acting at the ghrelin receptor. Its defining property is selectivity — it prompts growth hormone release with markedly less effect on cortisol, prolactin and appetite than the older GHRP compounds. This section carries 19 lines from £34 to £132, clustered near £52, making it one of the more affordable peptides stocked.

Why selectivity is the whole argument

Ipamorelin against the older ghrelin-receptor agonists

	Ipamorelin	GHRP-6	GHRP-2
GH release	Yes	Yes	Yes, strongest
Appetite increase	Minimal	Pronounced	Moderate
Cortisol effect	Minimal	Present	Present
Prolactin effect	Minimal	Present	Present

GHRP-6’s appetite effect is pronounced enough that it is sometimes used for that purpose rather than for growth hormone at all. Ipamorelin’s comparative cleanliness is why it became the default despite GHRP-2 producing a larger release — fewer downstream effects to manage.

Why it is paired with a GHRH analogue

Ipamorelin acts at the ghrelin receptor; CJC-1295 acts as a GHRH analogue at a different receptor. Because the two pathways are separate, the combined response exceeds either alone, which is why they are almost invariably run together rather than individually. This pairing is the most common protocol in the whole peptides category.

Dosing pattern and why frequency matters

Because natural growth hormone release is pulsatile, protocols aim to reproduce pulses rather than hold a continuous level. That means several small doses across the day rather than one large one — commonly on waking, post-training and before sleep, since those align with the body’s own release windows.

The before-sleep dose is the one most consistently reported as producing noticeable effect, which is consistent with the largest natural growth hormone pulse occurring during early deep sleep. Dosing on an empty stomach matters more than with most compounds here, because elevated blood glucose blunts growth hormone release regardless of what triggered it.

What to expect

Effects are slower and subtler than exogenous growth hormone, because the compound works within the ceiling your own pituitary imposes. Improved sleep quality is the most consistently reported effect, followed by recovery. Body composition change is real but gradual, measured over months rather than weeks.

That physiological ceiling is both the safety advantage and the limit. It is not an HGH substitute, and treating it as one produces disappointment — the honest comparison is in what HGH actually does.

Ipamorelin against exogenous growth hormone

The comparison people most want is against somatropin, and the honest answer is that they are not substitutes. Exogenous growth hormone raises circulating levels directly and without a ceiling; a secretagogue asks your pituitary to do more, and your pituitary has a maximum output. The secretagogue route is cheaper, gentler and constrained; the exogenous route is expensive, stronger and carries the insulin-resistance concern that comes with sustained elevation.

Which matters depends on the objective. For sleep quality and general recovery a secretagogue is a reasonable choice. As a replacement for somatropin at performance doses it is not equivalent, and the price gap between the two categories reflects that rather than contradicting it.

Who it suits and who it does not

It suits someone wanting gradual recovery and sleep improvement over months, who is comfortable with several small injections a day and is not expecting visible body composition change quickly. It suits impatience poorly, and it suits anyone hoping to replicate growth hormone results poorly for the reason above.

It is also a reasonable entry point into this category precisely because the ceiling is physiological — the failure mode is that not much happens, rather than that something goes badly wrong. That is not true of every compound stocked here, and it is a fair part of why ipamorelin is as widely used as it is.

Handling and legal position

Supplied lyophilised, reconstituted with bacteriostatic water, refrigerated afterwards. Not a controlled drug but an unlicensed medicine, so supply for human use is an offence while possession generally is not — see are peptides legal in the UK. Ultima Pharmaceuticals, Peptide Sciences and Euro Pharmacies carry the stocked lines at 2 mg and 5 mg.

Frequently asked questions

What does ipamorelin do to the body?
It stimulates the pituitary to release growth hormone via the ghrelin receptor, with less effect on cortisol, prolactin and appetite than older compounds in the same class.

Is ipamorelin legal in the UK?
It is not a controlled drug. It is an unlicensed medicine, so supplying it for human use is an offence; possession generally is not.

Who should avoid taking ipamorelin?
Anyone with an active cancer diagnosis, given growth signalling promotes proliferation generally, and anyone with unmanaged blood-glucose issues, since growth hormone opposes insulin.

Is ipamorelin better than GHRP-2?
Cleaner rather than stronger. GHRP-2 produces a larger release; ipamorelin produces fewer downstream effects.

How long before effects appear?
Sleep changes are often noticed within the first week or two. Body composition change is measured in months.